Factors influencing survival of 107 HER2 positive breast cancer patients treated with trastuzumab based neoadjuvant chemotherapy

被引：1
|
作者：
Favier, L. [1 ]
Guiu, S. [1 ]
Dunach, E. [1 ]
Assous, D. [1 ]
Bonnetain, F. [1 ]
Gligorov, J. [2 ]
Stockmeier, V. [3 ]
Vasseur, B. [4 ]
Fumoleau, P. [1 ]
Coudert, B. [1 ]
机构：
[1] Ctr Georges Francois Leclerc, Dijon, France
[2] Hop Tenon, F-75970 Paris, France
[3] Lab Sanofi Aventis, Paris, France
[4] Lab Roche, Paris, France
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70820-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5058
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] Eradication of Axillary Lymph Node Metastases Occurs in 74% of Patients Receiving Neoadjuvant Chemotherapy with Concurrent Trastuzumab for HER2 Positive Breast Cancer
    Dominici, L. S.
    Gonzalez, Negron V. M.
    Buzdar, A. U.
    Lucci, A.
    Mittendorf, E. A.
    Pusztai, L.
    Krishnamurthy, S.
    Le-Petross, H. T.
    Babiera, G.
    Bedrosian, I
    Meric-Bernstam, F.
    Hunt, K. K.
    Valero, V.
    Kuerer, H. M.
    CANCER RESEARCH, 2009, 69 (24) : 566S - 566S
  • [42] Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
    Katsuhiko Nakatsukasa
    Hiroshi Koyama
    Yoshimi Oouchi
    Seiichi Imanishi
    Naruhiko Mizuta
    Kouichi Sakaguchi
    Yoshifumi Fujita
    Aya Imai
    Akiko Okamoto
    Asako Hamaoka
    Mari Soushi
    Ikuya Fujiwara
    Tatsuya Kotani
    Takayuki Matsuda
    Kenichirou Fukuda
    Midori Morita
    Sadao Kawakami
    Yayoi Kadotani
    Eiichi Konishi
    Akio Yanagisawa
    Mariko Goto
    Kei Yamada
    Tetsuya Taguchi
    Breast Cancer, 2017, 24 : 92 - 97
  • [43] Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Oouchi, Yoshimi
    Imanishi, Seiichi
    Mizuta, Naruhiko
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Imai, Aya
    Okamoto, Akiko
    Hamaoka, Asako
    Soushi, Mari
    Fujiwara, Ikuya
    Kotani, Tatsuya
    Matsuda, Takayuki
    Fukuda, Kenichirou
    Morita, Midori
    Kawakami, Sadao
    Kadotani, Yayoi
    Konishi, Eiichi
    Yanagisawa, Akio
    Goto, Mariko
    Yamada, Kei
    Taguchi, Tetsuya
    BREAST CANCER, 2017, 24 (01) : 92 - 97
  • [44] Evaluating Trastuzumab in the treatment of HER2 positive breast cancer
    Jaques, Ryan
    Xu, Sam
    Matsakas, Antonios
    HISTOLOGY AND HISTOPATHOLOGY, 2020, 35 (10) : 1059 - 1075
  • [45] Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patients
    Ran Feng
    Lihui Pan
    Yarong Yao
    Jinnan Gao
    Xiaojun Zhang
    Oncology and Translational Medicine, 2025, 11 (02) : 73 - 80
  • [46] Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
    Knutson, Keith L.
    Clynes, Raphael
    Shreeder, Barath
    Yeramian, Patrick
    Kemp, Kathleen P.
    Ballman, Karla
    Tenner, Kathleen S.
    Erskine, Courtney L.
    Norton, Nadine
    Northfelt, Donald
    Tan, Winston
    Calfa, Carmen
    Pegram, Mark
    Mittendorf, Elizabeth A.
    Perez, Edith A.
    CANCER RESEARCH, 2016, 76 (13) : 3702 - 3710
  • [47] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [48] Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
    Ginzac, Angeline
    Bernadach, Maureen
    Molnar, Ioana
    Duclos, Martine
    Thivat, Emilie
    Durando, Xavier
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [50] Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia
    Rodriguez, Mauricio
    Gonzalez, Diego M.
    El-Sharkawy, Farah
    Castano, Mileny
    Madrid, Jorge
    BIOMEDICA, 2023, 43 (03): : 396 - 405
12345